Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Security

EQHA · EQ Health Acquisition Corp.

EQHANASDAQCommon stockHistorical · closed Dec 21, 2022CIK 1826729Updated Sep 25, 2026

Company: EQ Health Acquisition Corp. →

EQHA price & chart

Provider market data
Historical security

This listing closed Dec 21, 2022. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

  1. 15-12G filing

    15-12G · 2023-01-17 · 0001104659-23-003899

  2. 25-NSE filing

    25-NSE · 2022-12-28 · 0000876661-22-001211

  3. 8-K filing

    8-K · 2022-12-23 · 0001104659-22-129736

  4. 8-K/A filing

    8-K/A · 2022-12-12 · 0001104659-22-126231

  5. 8-K filing

    8-K · 2022-12-09 · 0001104659-22-125963

Show 5 more recent filings
  1. 25-NSE filing

    25-NSE · 2022-12-07 · 0000876661-22-001100

  2. DEF 14A filing

    DEF 14A · 2022-12-06 · 0001104659-22-124931

  3. PRE 14A filing

    PRE 14A · 2022-11-22 · 0001104659-22-121319

  4. 10-Q filing

    10-Q · 2022-11-14 · 0001410578-22-003205

  5. 10-Q filing

    10-Q · 2022-08-15 · 0001410578-22-002448

Financials

FY 2021 · USD
Revenue— · FY 2021
Net income— · FY 2021
Operating income— · FY 2021
Diluted EPS— · FY 2021

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2021FY 2020
ASSETS
AssetsUSD220,392,326
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

210,769
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD50,039
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

21,900
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Assets, CurrentUSD286,954
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD18,778,598
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

—
Stockholders’ equity:
Additional Paid in CapitalUSD—24,450
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Retained Earnings (Accumulated Deficit)USD-18,386,422
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

-1,000
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Stockholders' Equity Attributable to ParentUSD-18,385,872
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

24,000
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Liabilities and EquityUSD220,392,326
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

210,769
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Current liabilities:
Liabilities, CurrentUSD2,030,342
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

186,769
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD1,995,342
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

1,000
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2021FY 2020
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD6,955,943
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD-1,479,836
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-219,999,600
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD221,507,575
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD28,139
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD50,039
Source

10-K · 2022-03-31 · 0001410578-22-000794

As of 2021-12-31

21,900
Source

10-K · 2021-03-31 · 0001104659-21-044231

As of 2020-12-31

Additional Financial Items
Net Income (Loss) Attributable to ParentUSD6,955,943
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—
Nonoperating Income (Expense)USD10,173,533
Source

10-K · 2022-03-31 · 0001410578-22-000794

2021-01-01 to 2021-12-31

—

Lines labelled “Derived” are calculated from reported figures.